MCL1 and B-cell chronic lymphocytic leukemia: The apoptotic effect of DT-061 on CLL cells was also supported by the increased cleavage of PARP and the reduced expression of the antiapoptotic Mcl-1 protein observed in DT-061-treated cells compared with controls (n = 8; Fig. 6B).